Indoco Remedies has received EU GMP certification from the Competent Health Authority of Germany for its manufacturing site situated at HB 211 Village Katha, IN- 173 205 Baddi, Tehsil- Nalagarh, District - Solan. The Agency conducted an inspection at Indoco's manufacturing facility for oral dosage form (Baddi -III), from May 22 - 25, 2023.
The EU GMP certification issued by the German Health Authority (Berlin) confirms that the site complies with the Good Manufacturing Practice requirements as referred in the EC Directive. The EU certification will support supplies of drug products registered in Europe, from this manufacturing site.
Commenting on the development, Ms. Aditi Panandikar, Managing Director - Indoco Remedies Ltd., said that "The EU GMP certification for our site in Baddi adds to our consistent efforts to supply quality and affordable medicines in Europe. We are committed to being cGMP compliant and supplying quality products to our customers and patients across the globe."
Shares of Indoco Remedies Limited was last trading in BSE at Rs. 329.95 as compared to the previous close of Rs. 328.90. The total number of shares traded during the day was 6141 in over 381 trades.
The stock hit an intraday high of Rs. 334.95 and intraday low of 326.20. The net turnover during the day was Rs. 2029974.00.